-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pharmaceutical Network Industry Dynamics: Pharmaceutical market structure continues to divide, the future of China's biopharmaceutical market share will gradually expand, the size of the industry market shows a growing trend year by yearData forecast that 2016-2021 China's biopharmaceutical industry will maintain a compound annual growth rate of 16.4%, by 2021, the size of the biopharmaceutical market will reach 326.9 billion yuanWith the increasing demand for biomedicine in the market and the rapid development of biopharmaceutical field, the industry's demand for biopharmaceutical technology and equipment has put forward higher requirements, in which pharmaceutical processes in the selection of more close to energy conservation and environmental protection, recycling, intelligent automation and so onNow with the deepening of energy conservation and environmental protection policy, biopharmaceuticals in the end treatment, how to more energy-saving treatment of pollutants has become a focus of pharmaceutical companies to consider the issueIt is reported that continuous inactivated processing equipment with the breakthrough of technology, was pushed to the tip of the wind
Traditional inactivated treatment process there is a certain short board China's current focus in the field of biomedicine, including geneticengineering drugs, active proteins and peptide drugs, Chinese herbal medicine and its effective bioactive ingredientextraction, fermentation production, a variety of vaccines, monoantigen and enzyme diagnosis and treatment reagents, targeted drugsPharmaceutical plants in these areas produce large amounts of biological wastewater in experiments and production processes, which contain large amounts of bacteria, proteins, and harmful impurities such as cells, and the direct discharge of untreated biological wastewater affects the surrounding environmentIn order to prevent infected bacteria, proteins, cells with the discharge of wastewater, biological wastewater before discharge must be inactivated treatment
Usually in the treatment of biological toxic waste water problems, the use of inactivation process including heating inactivation, chemical inactivation, UV killing, etc, enterprises generally choose traceable, verifiable heating inactivation as the main treatment processIt is worth noting that these traditional inactivated treatment process has a certain short plate, which not only deals with long time, rigid, but also usually accompanied by a series of problemsIf the protein preheating in the waste liquid will solidify into flocs or clumps of solids, blocking the pipe or wall, the amount of steam is large, the treatment workshop odor is obvious, the cooling water is large, the steam supply needs to be re-treated after the interruption
Taking chemical inactivation as an example, the process is not only at the level of manual operation, low efficiency, but also in the process of operation needs to add chemicals to the wastewater, and the addition of chemical agents will cause secondary pollution of wastewater
Continuous inactivation treatment equipment to effectively solve the problem of energy consumption, much attention in recent years, China through the accumulation of months, the overall level of the biopharmaceutical industry to achieve a significant increaseBut in the field of biopharmaceuticals, there are a large number of toxic wastewater needs to be inactivated after discharge, and most of the current is intermittent completion, this intermittent inactivation method often exists high energy consumption, not easy to control, resulting in inactivation is not complete and so on
In order to solve the problem of biopharmaceutical wastewater discharge, China's pharmaceutical equipment industry is also constantly exploring, in which continuous inactivated treatment equipment has been widely concerned by the industry It is understood that the safety and stability of the new biopharmaceutical wastewater continuous inactivation treatment device is higher, with low energy consumption, good inactivation effect and so on, and better meet the needs of biopharmaceutical enterprises Such as a series of continuous inactivation treatment equipment designed and developed by an enterprise, it effectively solves the energy consumption problem of traditional inactivated equipment, the problem of space occupation, maintenance and operation problems
"After the waste water collection, first preheat, and then enter the insulation area for sterilization treatment, after sterilization of the wastewater heat is quite high, so then this part of the heat recycling, for the subsequent preheating of wastewater, so that for the follow-up wastewater heating to inactivated temperature, can save a lot of steam consumption, and inactivated wastewater after heat exchange, can also save the use of cooling water." The above-mentioned enterprises said that its continuous inactivation treatment equipment has a dual energy-saving effect, that is, not only to save the use of heating section steam, but also to do not need cooling water for cooling In addition, the equipment also has a self-check function, before starting, the equipment will check to determine whether the pipeline is blocked, inactivated temperature has not reached the set value, to ensure that the equipment will not be inactivated after the loss
The development of biopharmaceutical industry has broad prospects, the future will maintain a good momentum of growth, but biopharmaceuticals in the production process will also produce toxic microorganisms, such as bacteria, viruses and other wastewater, these wastewater will cause serious harm to the environment and human health In recent years, with the promotion of energy conservation and emission reduction and other policies in China and the vigorous development of the biopharmaceutical industry, the issue of biopharmaceutical wastewater has been paid more and more attention The industry said that continuous inactivation technology in the treatment of biopharmaceutical wastewater, especially large-scale vaccine production line wastewater inactivated treatment has achieved a huge breakthrough, applications will be more and more extensive.